Letteratura scientifica selezionata sul tema "Wharton’s jelly"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Wharton’s jelly".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Wharton’s jelly"
Amin, Sapna, Shripad Hebbar, Deepika Pothakamuri e Prashant Adiga. "Significance of Wharton’s jelly area in prediction of aberrant foetal growth". International Journal of Reproduction, Contraception, Obstetrics and Gynecology 7, n. 7 (27 giugno 2018): 2820. http://dx.doi.org/10.18203/2320-1770.ijrcog20182888.
Testo completoSeo, Min-Soo, Kyung-Ku Kang, Se-Kyung Oh, Soo-Eun Sung, Kil-Soo Kim, Young-Sam Kwon e Sungho Yun. "Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells". Veterinary Sciences 8, n. 2 (7 febbraio 2021): 24. http://dx.doi.org/10.3390/vetsci8020024.
Testo completoGogiel, Tomasz, Edward Bańkowski e Stefan Jaworski. "Proteoglycans of Wharton’s jelly". International Journal of Biochemistry & Cell Biology 35, n. 10 (ottobre 2003): 1461–69. http://dx.doi.org/10.1016/s1357-2725(03)00128-6.
Testo completoMurphy, Sarah J., Nikita Deegan, Bobby D. O'Leary e Peter McParland. "Absence of Wharton’s jelly". BMJ Case Reports 13, n. 11 (novembre 2020): e237222. http://dx.doi.org/10.1136/bcr-2020-237222.
Testo completoDhitiseith, D., e S. Honsawek. "Differential Expression of Osteogenic Differentiation in Human Umbilical Cord Wharton’s Jelly-Derived Mesenchymal Stem Cells Treated with Demineralized Bone". Advanced Materials Research 55-57 (agosto 2008): 697–700. http://dx.doi.org/10.4028/www.scientific.net/amr.55-57.697.
Testo completoŚwistowska, Małgorzata, Paulina Gil-Kulik, Arkadiusz Krzyżanowski, Tomasz Bielecki, Marcin Czop, Anna Kwaśniewska e Janusz Kocki. "Potential Effect of SOX2 on the Cell Cycle of Wharton’s Jelly Stem Cells (WJSCs)". Oxidative Medicine and Cellular Longevity 2019 (2 giugno 2019): 1–8. http://dx.doi.org/10.1155/2019/5084689.
Testo completoRajasekharan, Sreekumar, UmesanKannanvilakom Govindapillai, Manju Madhavan C., Suja R. S., Swapna T e Sajeena Narayanan Chitradevi. "To Estimate the Importance of Wharton’s Jelly in the Growth of the Foetus – A Light Microscopic Study". Journal of Evolution of Medical and Dental Sciences 10, n. 35 (30 agosto 2021): 3024–29. http://dx.doi.org/10.14260/jemds/2021/617.
Testo completoStocco, Elena, Silvia Barbon, Daniele Dalzoppo, Silvano Lora, Leonardo Sartore, Marcella Folin, Pier Paolo Parnigotto e Claudio Grandi. "Tailored PVA/ECM Scaffolds for Cartilage Regeneration". BioMed Research International 2014 (2014): 1–12. http://dx.doi.org/10.1155/2014/762189.
Testo completoBehera, Shashi Shankar, Shashi Shankar Behera e Prafulla Kumar Chinara. "EVALUATION OF FETAL WEIGHT SONOGRAPHICALLY USING AREA OF WHARTON’S JELLY AND MORPHOLOGY OF UMBILICAL CORD". Asian Journal of Pharmaceutical and Clinical Research 10, n. 10 (1 settembre 2017): 253. http://dx.doi.org/10.22159/ajpcr.2017.v10i10.20037.
Testo completoStefańska, Katarzyna, Katarzyna Ożegowska, Greg Hutchings, Małgorzata Popis, Lisa Moncrieff, Claudia Dompe, Krzysztof Janowicz et al. "Human Wharton’s Jelly—Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials". Journal of Clinical Medicine 9, n. 4 (12 aprile 2020): 1102. http://dx.doi.org/10.3390/jcm9041102.
Testo completoTesi sul tema "Wharton’s jelly"
Seshareddy, Kiran Babu. "Human Wharton’s jelly cells-isolation and characterization in different growth conditions". Thesis, Kansas State University, 2008. http://hdl.handle.net/2097/1054.
Testo completoDepartment of Anatomy and Physiology
Mark L. Weiss
Wharton's jelly is a non-controversial source of mesenchymal stromal cells. Isolation of the cells is non-invasive and painless. The cells have been shown to have a wide array of therapeutic applications. They have improved symptoms when transplanted in a variety of animal disease models, can be used in tissue engineering applications to grow living tissue ex vivo for transplantation, and can be used as drug delivery vehicles in cancer therapy. The cells have also been shown to be non-immunogenic and immune suppressive. This thesis focuses on optimizing isolation protocols, culture protocols, cryopreservation, and characterization of cells in different growth conditions. Results from the experiments indicate that isolation of cells by enzyme digestion yields cells consistently, a freezing mixture containing 90% FBS and 10% DMSO confers maximum viability, and the expression of mesenchymal stromal cell consensus markers does not change with passage and cryopreservation. The results of the experiments also show that cells grow at a higher rate in 5% oxygen culture conditions compared to 21% oxygen culture conditions, serum does not have an effect on growth of the cells, serum and oxygen do not have effects on the expression of mesenchymal stromal cell consensus markers and the cells are stable without nuclear abnormalities when grown in 5% oxygen and serum free conditions for six passages after first establishing in serum conditions.
Morton, Jodi Mirissa. "Effects of intrauterine growth restriction on Wharton’s jelly cells and preweaning traits in pigs". Diss., Kansas State University, 2018. http://hdl.handle.net/2097/38757.
Testo completoDepartment of Animal Sciences and Industry
Duane L. Davis
Intrauterine growth restriction (IUGR) affects all mammals. In the swine industry IUGR pigs result from intrauterine crowding. Prenatal programming in IUGR pigs has substantial effects on myogenesis and adipogenesis. Prenatal programming due to IUGR is also a problem in humans and long-term effects on adipogenesis are well established for small for gestational age (SGA) babies. Mesenchymal stem cells (MSCs) are the precursors for adipocytes. The umbilical cord contains a population of MSCs in Wharton’s jelly (WJ) and they can be harvested postnatally without ethical issues. Therefore, WJMSCs are proposed as models for studying prenatal programming of adipogenesis. We selected genes from studies of adipogenesis in humans and other species and examined their expression in pig WJ. We assigned pigs within litter as High, Medium, or Low birth weight and evaluated these categories for expression of Cox1, Cox2, EGR1, PPARɣ1, PPARɣ2, and Pref1. Differences due to size classification within litter were limited but there were correlations between weaning weight and delta cycle threshold (ΔCt) for EGR1 (r = 0.28; P < 0.009), PPARɣ1 (r = 0.29; P < 0.007), and PPARɣ2 (r = 0.30; P < 0.005). This may be consistent with the reports for SGA babies where EGR1 is upregulated by prenatal growth restriction. To gain insight into when during pregnancy IUGR affects WJ cells we collected umbilical cords at d 60 and d 95. In d 60 umbilical cords, small fetuses had increased (P = 0.06) Cox1 gene expression. We tested the ability of d 60 WJ cells to undergo adipogenic differentiation using standard protocols and a cycling protocol that exposed the cells to adipogenic differentiation conditions interposed with a rest phase with high insulin. It has been reported that the cycling protocol revealed increased glucose uptake in WJ cells from human SGA babies. We found that d 60 WJ cells did not show adipogenic differentiation in any of the protocols tested however glucose uptake correlated negatively with birth weight at Cycle 0 (P < 0.02; r = 0.61). In summary, pig WJ cells reveal some effects of IUGR but they appear to differ from the relationship demonstrated reported for human SGA babies. A new finding was that at midgestation pig WJ cells do not appear to be competent to complete adipogenesis. We also studied nursing managements to improve outcomes for IUGR pigs. Colostrum intake may be a problem, particularly for light weight pigs and those born later during farrowing. Split suckling is the removal of some pigs to allow others unrestricted nursing access. We temporarily removed the six heaviest pigs and this treatment increased gain and weight by d 7 of age. Colostrum intake was highest for the high birth weight pigs. When we temporarily removed the first half of the litter, colostrum intake was increased for the second half of litter born and the difference in immunocrit was reduced between the two litter halves.
Reeds, Kimberly. "In vitro effects of canine Wharton’s jelly mesenchymal stromal cells and nanoparticles on canine osteosarcoma D17 cell viability". Thesis, Kansas State University, 2011. http://hdl.handle.net/2097/11990.
Testo completoDepartment of Clinical Sciences
Mary Lynn Higginbotham
Objectives – To isolate and maintain canine Wharton’s jelly mesenchymal stromal cells (WJMSCs) in culture, to determine the effects of micellar nanoparticles containing doxorubicin (DOX) on WJMSCs and canine osteosarcoma (OSA) D17 cell viability, and to determine the effects of conditioned media from WJMSCs loaded with micellar nanoparticles containing DOX on OSA D17 cell viability. Sample Population – Canine WJMSCs containing various concentrations of DOX micelles and canine OSA D17 cells. Procedures – WJMSCs were isolated from canine umbilical cords. Micellar nanoparticles containing DOX were prepared and added to culture plates containing canine OSA D17 cells to determine micelle effects on cell growth and viability. Conditioned media from culture plates containing canine WJMSCs incubated with various DOX micelle concentrations was added to OSA D17 cells for conditioned media experiments. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed to assess OSA D17 cell viability. A trypan blue stain was also utilized to perform cell counts to determine the effect of the DOX micelles on stromal cell growth. Results – WJMSCs were successfully isolated and maintained in culture. Micellar nanoparticles containing DOX decreased OSA D17 cell viability. OSA D17 cell viability was also decreased following incubation with conditioned media from canine WJMSCs loaded with micellar nanoparticles containing DOX. Significant decreases with the conditioned media of canine WJMSCs loaded with 10μM micelles occurred at 48 hours (p < 0.005) and at 72 and 96 hours (p < 0.0001). Significant decreases were also observed with the 1 μM DOX micelles at 72 hours (p < 0.005) and 96 hours (p < 0.0001). WJMSC numbers decreased in a dose dependent manner following incubation with DOX micelles. Changes in WJMSC number was not caused by increased cell death as all variables produced similar percentages of dead cells. Conclusions – Canine WJMSCs were successfully isolated and maintained in culture. Stromal cells containing DOX micellar nanoparticles induced OSA D17 cell cytotoxicity while inducing an anti-proliferative, rather than cytotoxic effect, on the WJMSC. These data support future in vivo experiments utilizing canine WJMSCs and micellar nanoparticles.
Sankaramaddi, Jeevan Reddy [Verfasser]. "Evaluation of human umbilical cord Wharton’s Jelly Cells as a potential cell source for cardiovascular tissue engineering / Jeevan Reddy Sankaramaddi". Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2017. http://d-nb.info/1148425780/34.
Testo completoFerreira, Daniela Filipa Alves. "Influence of substrates composition on immunomodulation by MSCs". Master's thesis, Universidade de Aveiro, 2016. http://hdl.handle.net/10773/16048.
Testo completoMesenchymal stem cells (MSCs) are non-hematopoietic multipotent stem cells capable to self-renew and differentiate along different cell lineages. MSCs can be found in adult tissues and extra embryonic tissues like the umbilical cord matrix/Wharton’s Jelly (WJ). The latter constitute a good source of MSCs, being more naïve and having a higher proliferative potential than MSCs from adult tissues like the bone marrow, turning them more appealing for clinical use. It is clear that MSCs modulate both innate and adaptive immune responses and its immunodulatory effects are wide, extending to T cells and dendritic cells, being therapeutically useful for treatment of immune system disorders. Mechanotransduction is by definition the mechanism by which cells transform mechanical signals translating that information into biochemical and morphological changes. Here, we hypothesize that by culturing WJ-MSCs on distinct substrates with different stiffness and biochemical composition, may influence the immunomodulatory capacity of the cells. Here, we showed that WJ-MSCs cultured on distinct PDMS substrates presented different secretory profiles from cells cultured on regular tissue culture polystyrene plates (TCP), showing higher secretion of several cytokines analysed. Moreover, it was also shown that WJ-MSCs cultured on PDMS substrates seems to possess higher immunomodulatory capabilities and to differentially regulate the functional compartments of T cells when compared to MSCs maintained on TCP. Taken together, our results suggest that elements of mechanotransduction seem to be influencing the immunomodulatory ability of MSCs, as well as their secretory profile. Thus, future strategies will be further explored to better understand these observation and to envisage new in vitro culture conditions for MSCs aiming at distinct therapeutic approaches, namely for immune-mediated disorders.
As células estaminais mesenquimais (MSCs) são células não-hematopoéticas, multipotentes, capazes de se auto-renovar e de diferenciar em diferentes tipos celulares. As MSCs estão presentes em tecidos mesenquimais e de tecidos extra embrionários, tais como a matriz do cordão umbilical/Wharton’s Jelly(WJ). Estes últimos constituem uma boa fonte de de MSCs, sendo estas mais naive e tendo um maior potencial de proliferação do que as MSCs obtidas de tecidos adultos, como a medula óssea, tornando as MSCs da matriz do cordão umbilical/Wharton’s Jelly sejam mais apelativas para uso clínico. As MSCs possuem a capacidade de modularem tanto o sistema imune inato como o adquirido e os seus efeitos são vastos, afectando todas as células do sistema imune. Esta capacidade é bastante vantajosa para o uso terapêutico destas células em doenças do sistema imunitário. A mecanotransducção é por definição o mecanismos pelo qual as células convertem estímulos mecânicos em uma resposta bioquímica e com mudanças na sua morfologia. Apartir destas observações colocámos a hipotese de que mantendo MSCs in vitro em diferentes substratos poderia influencia a sua capacidade imunomoduladora. Com este trabalho, demonstrámos que ao plaquear MSCs em diferentes substratos de PDMS, estas mostram uma tendência para secretar quantidades diferentes de vários factores soluveis analisados, relativamente a MSCs mantidas em cultura em plataformas convencionais (placas de cultura de células - TCP). Para além disto, foi também observado que MSCs plaqueadas em substratos de PDMS aparentavam possuir uma maior capacidade imunomoduladora quando comparadas com MSCs mantidas em condições convencionais. Em conjunto todos os resultados obtidos sugerem que elementos relacionados com a mecanotransdução parecem influenciar a capacidade imunomoduladora de MSCs e a sua secreção de factores solúveis. Deste modo, estudos futuros poderão elucidar os mecanismos responsáveis por estas observações, de modo a permitir que se possa constitutuir melhores estratégias de cultura de MSCs para futuro uso terapêutico dirigido a doenças do sistema imunitário.
Laroye, Caroline. "Le cordon ombilical : une source alternative de cellules souches/stromales mésenchymateuses dans le traitement du choc septique ?" Thesis, Université de Lorraine, 2017. http://www.theses.fr/2017LORR0279.
Testo completoSeptic shock, equal to the myocardial infraction, is currently the tenth cause of death in the world. The pathophysiological complexity of this syndrome, with a simultaneous pro and anti- inflammatory state, results in the failure of conventional treatments. In this sense, research is focusing on innovative therapeutics agent, including mesenchymal stem cells (MSC). Indeed, murine studies of septic shock showed that MSC improve organ injuries, bacteremia and survival by notably a paracrine mechanism. However, MSC properties vary according to the source tissue, especially if they are derived from a fetal tissue (Wharton’s jelly (WJ), placenta amniotic fluid) or an adult tissue (bone marrow (BM), adipose tissue...). Our first objective was to compare, in a septic shock murine model, the effect of BM-MSC with that of WJ-MSC. Although some differences were observed, the same efficiency was demonstrated between these two sources. However, WJ-MSC present large advantages in comparison to BM-MSC due to their important proliferation capacities and potential quantities of umbilical cord donation. Consequently, our second objective was to investigate the effect of WJ-MSC administration in a relevant pig model of peritonitis in order to better mimic a clinical approach in humans. This study, conducted in double-blind and in presence of an experimented intensivist, showed that WJ-MSC produced in clinical grade and used immediately after thawing, improve survival, hemodynamic parameters and organ injuries by another action than that described in murine studies
Reppel, Loïc. "Potentialité des cellules stromales de la gelée de Wharton en ingénierie du cartillage". Thesis, Université de Lorraine, 2014. http://www.theses.fr/2014LORR0164/document.
Testo completoMesenchymal Stromal/Stem Cells from human Wharton’s jelly (WJ-MSC) are an abundant and interesting source of stem cells for applications in cell and tissue engineering. Their fetal origin confers specific characteristics compared to Mesenchymal Stromal/Stem Cells isolated from human bone marrow (BM-MSC). First, the aim of this work is to optimize WJ-MSC culture conditions for their subsequent clinical use. We focus on the influence of oxygen concentration during monolayer expansion on several parameters to characterize MSC. The results are compared to those obtained with BM-MSC. Our work distinguishes WJ-MSC from BM-MSC in terms of proliferation and adipogenic differentiation. Considering our results, hypoxia during cell expansion is an important parameter to take into account regarding proliferation potential but also chondrogenic differentiation potential. The influence of obstetric factors on WJ-MSC characteristics is also explored. In cartilage tissue engineering context, the second phase of the project is to induce cell differentiation into chondrocytes by seeding them in Alginate/Hyaluronic Acid hydrogel scaffold, and during 28 days. The results obtained are compared to those obtained with BM-MSC. After 4 weeks of culture, WJ-MSC are able to adapt to their environment and express specific cartilage-Related genes and matrix proteins such as type 2 collagen, which is found more expressed after differentiation fromWJ-MSC, than from BM-MSC
Yu, Hao. "Évaluation des caractéristiques des hydrogels d’alginate supplémentés en acide hyaluronique ou en hydroxyapatite lors de la différenciation des cellules souches mésenchymateuses issues de la gelée de Wharton". Thesis, Université de Lorraine, 2017. http://www.theses.fr/2017LORR0087/document.
Testo completoIn the field of cartilage engineering, alginate (Alg)-based hydrogels and mesenchymal stem cells (MSC) are widely used as raw biomaterials and stem cells which can be used to fill cartilage lesions of varying depth. However, to reproduce the zonal organization of articular cartilage, a graft multilayer is necessary. In order to guide the differentiation of MSCs in different strata of the biomaterials, without input of growth factors, natural cartilage components (hyaluronic acid, HA) or bone matrix (hydroxyapatite, Hap) can be added into the alginate. The aim of this work is to analyze the impact of the composition of alginate enriched either in HA or in Hap on the behavior of MSCs. The first part of our work is to evaluate the behavior of WJ-MSCs into these hydrogels. Our results have shown that Alg/ Hap hydrogels not only possess better mechanical properties than Alg/HA hydrogels, but also promote the viability of MSCs and their differentiation from MSC seeded into the Alg/HA hydrogel. The sterilization method of biomaterial is an essential step, the multiple effects of which must be evaluated, in particular as regards the behavior of the cells, but also to maintain the integrity of the physicochemical properties of hydrogel. Thus, in a second part of this work, we showed that the autoclave sterilization treatment induced a negative effect on the initial characteristics of alginate hydrogel. It is also apparent from this investigation of the sterilization modes that the sterilization of hydrogels with UV is more efficient and makes it possible to preserve the specific properties of the hydrogel as best as possible, in particular Alg/HA. Finally, in a third part of our work, we also evaluated the evolution of the mechanical properties during the differentiation and the impact of these on the differentiation of MSCs and their immunomodulatory properties. From these results, we have shown that the physico-chemical characteristics of Alg / ha and Alg/hap hydrogels influence not only the differentiation potential of WJ-MSC but also the secretion of soluble factors involved in immunomodulation. Since these physicochemical properties are influenced by the sterilization process, it is advisable to take them into account in all stages of tissue engineering
Seshareddy, Kiran Babu. "Human Wharton's jelly cells-isolation and characterization in different growth conditions". Manhattan, Kan. : Kansas State University, 2008. http://hdl.handle.net/2097/1054.
Testo completoBadraiq, Heba Ghazi O. "Effects of maternal body weight on Wharton's Jelly mesenchymal stromal cells (pilot study)". Thesis, King's College London (University of London), 2017. https://kclpure.kcl.ac.uk/portal/en/theses/effects-of-maternal-body-weight-on-whartons-jelly-mesenchymal-stromal-cells-pilot-study(dac6be9c-1f9d-4c00-88dc-2a73ec4489b4).html.
Testo completoLibri sul tema "Wharton’s jelly"
Sarugaser, Rahul. Human umbilical cord Wharton's jelly as a source of mesenchymal progenitors capable of expressing a functional osteogenic phenotype in vitro. 2004.
Cerca il testo completoCapitoli di libri sul tema "Wharton’s jelly"
Bastawrous, Marina, Mibel M. Pabón, Sandra Acosta, Ike de la Peña, Diana Hernandez-Ontiveros, Meaghan Staples, Kazutaka Shinozuka et al. "Wharton’s Jelly Stem Cells". In Fetal Stem Cells in Regenerative Medicine, 257–76. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3483-6_14.
Testo completoWalker, John T., Armand Keating e John E. Davies. "Stem Cells: Umbilical Cord/Wharton’s Jelly Derived". In Cell Engineering and Regeneration, 237–64. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-08831-0_10.
Testo completoWalker, John T., Armand Keating e John E. Davies. "Stem Cells: Umbilical Cord/Wharton’s Jelly Derived". In Cell Engineering and Regeneration, 1–28. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-37076-7_10-1.
Testo completoConverse, Gabriel L., Dandan Li, Eric E. Buse, Richard A. Hopkins e Omar S. Aljitawi. "Wharton’s Jelly Matrix Decellularization for Tissue Engineering Applications". In Methods in Molecular Biology, 25–33. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/7651_2017_61.
Testo completoBaba, Kyoko, Yasuharu Yamazaki, Akira Takeda e Eiju Uchinuma. "Bone Regeneration Using Wharton’s Jelly Mesenchymal Stem Cells". In Perinatal Stem Cells, 299–311. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1118-9_27.
Testo completoWeiss, Jeffrey N. "Wharton’s Jelly-derived Mesenchymal Stem Cells in Osteoarthritis". In Orthopedic Stem Cell Surgery, 115–21. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-73299-8_20.
Testo completoWeiss, M. L., Yelica López e K. R. McIntosh. "Wharton’s Jelly-Derived Mesenchymal Stromal Cells as Immunoregulatory Cells". In Human Fetal Tissue Transplantation, 87–105. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-4171-6_7.
Testo completoWeiss, Jeffrey N. "Wharton’s Jelly Originated Mesenchymal Stem Cell in Gonarthrosis (WHAMKO)". In Orthopedic Stem Cell Surgery, 229–33. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-73299-8_45.
Testo completoMellott, Adam J., Michael S. Detamore e Hinrich Staecker. "The Use of Human Wharton’s Jelly Cells for Cochlear Tissue Engineering". In Methods in Molecular Biology, 319–45. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3615-1_19.
Testo completoWeiss, Jeffrey N. "Use of Wharton’s Jelly-Derived Mesenchymal Stem Cells for Knee Osteoarthrosis". In Orthopedic Stem Cell Surgery, 239–41. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-73299-8_47.
Testo completoAtti di convegni sul tema "Wharton’s jelly"
Kerékgyártó, Márta, Emőke Kiss-Tóth, László Barkai e Bertalan Fodor. "The Role of Wharton’s Jelly Mesenchymal Stem Cells in Diabetes Mellitus". In MultiScience - XXX. microCAD International Multidisciplinary Scientific Conference. University of Miskolc, 2016. http://dx.doi.org/10.26649/musci.2016.146.
Testo completoDougherty, John, Emily Schaefer, Ryan Niemeier, Erin Koch, Craig Cady e Kalyani Nair. "Effect of Valproic Acid on Cell Proliferation of Wharton’s Jelly MSC in PCL Nanofiber Scaffolds". In ASME 2013 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/imece2013-65041.
Testo completoBarlian, Anggraini, Hermawan Judawisastra, Ahmad Ridwan, Antonia Ratih e Noviana Vanawati. "Differentiation of human Wharton’s jelly mesenchymal stem cells on biomaterial-based scaffold for cartilage tissue engineering". In THE 4TH BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, HEALTH, AND MEDICAL DEVICES: Proceedings of the International Symposium of Biomedical Engineering (ISBE) 2019. AIP Publishing, 2019. http://dx.doi.org/10.1063/1.5139328.
Testo completoHernando, A., D. H. A. Saputri, M. I. Tan e A. Barlian. "Directing the chondrogenic differentiation of human Wharton’s jelly mesenchymal stem cells using spider silk-based micropattern". In PROCEEDINGS OF THE INTERNATIONAL CONFERENCE AND SCHOOL ON PHYSICS IN MEDICINE AND BIOSYSTEM (ICSPMB): Physics Contribution in Medicine and Biomedical Applications. AIP Publishing, 2021. http://dx.doi.org/10.1063/5.0048014.
Testo completoWidowati, Wahyu, Teresa Liliana Wargasetia, Fanny Rahardja, Rimonta F. Gunanegara, Tri Handayani, Hanna Sari Widya Kusuma, Seila Arumwardana, Cahyaning Riski Wijayanti e Rizal Rizal. "Potential of Human Wharton’s Jelly Mesenchymal Stem Cells (hWJMSCs) Secretome for COVID-19 Adjuvant Therapy Candidate". In 2021 IEEE International Conference on Health, Instrumentation & Measurement, and Natural Sciences (InHeNce). IEEE, 2021. http://dx.doi.org/10.1109/inhence52833.2021.9537290.
Testo completoSharma, Mayank, Michael Bellio, Jian Huang, Pingping Chen, Andreas Damianos, Augusto Scmidt, Shu Wu et al. "Wharton’s Jelly Mesenchymal Stem Cell-derived (WJ-MSC) exosomes for Severe Bronchopulmonary Dysplasia: A Dose-Finding Study". In AAP National Conference & Exhibition Meeting Abstracts. American Academy of Pediatrics, 2021. http://dx.doi.org/10.1542/peds.147.3_meetingabstract.752.
Testo completoMartin, John T., e Virginia L. Ferguson. "Regional Similarities in the Mechanical Properties of the Human Umbilical Artery". In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206800.
Testo completoArrochman, Ferry, Eva Niamuzisilawati, Nurrachmat Mulianto e Indah Julianto. "The Effect of Conditioned Medium Derived Wharton’s Jelly Messenchymal Stem Cell for Diabetic Foot Ulcer: Preeliminary Study – Case Series". In The 23rd Regional Conference of Dermatology 2018. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008161305260528.
Testo completoRizal, Rahimi Syaidah, Ziyan Muhammad Aqsha, Adella Josephin e Vidi Miranda Pakpahan. "Characterization, differentiation, and population doubling time of Wharton’s jelly mesenchymal stem cells (WJ-MSCs) in passage 5 and 8". In THE 5TH BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, AND MEDICAL DEVICES: Proceedings of the 5th International Symposium of Biomedical Engineering (ISBE) 2020. AIP Publishing, 2021. http://dx.doi.org/10.1063/5.0047340.
Testo completoBarlian, A., H. Judawisastra, A. Ridwan, A. R. Wahyuni e M. E. Lingga. "Attachment, spreading, and proliferation of Wharton’s jelly mesenchymal stem cells on scaffold combination of silk fibroin and Argiope appensa silk spidroin". In PROCEEDINGS OF THE INTERNATIONAL CONFERENCE AND SCHOOL ON PHYSICS IN MEDICINE AND BIOSYSTEM (ICSPMB): Physics Contribution in Medicine and Biomedical Applications. AIP Publishing, 2021. http://dx.doi.org/10.1063/5.0048163.
Testo completo